MyFinsight
Home
Blog
About
Maturities of investments
$49,117K
Proceeds from exercise of
stock options
$732K
Net cash (used in)
provided by investing...
$31,294K
Net cash provided by
(used in) financing...
$532K
Canceled cashflow
$17,823K
Canceled cashflow
$200K
Net increase
(decrease) in cash, cash...
$11,510K
Canceled cashflow
$20,316K
Purchases of investments
$17,640K
Purchase of property and
equipment
$183K
Accrued liabilities
$5,954K
Stock-based compensation
expense
$4,598K
Accounts payable
$983K
Prepaid expenses and
other assets
-$943K
Depreciation and
amortization
$552K
Principal payments of
finance lease liability
$142K
Proceeds from private
placement financing, net...
-$58K
Net cash used in
operating activities
-$20,316K
Canceled cashflow
$13,030K
Net loss
-$32,246K
Net amortization of
premiums and accretion of...
$756K
Operating lease
liabilities
-$344K
Back
Back
Cash Flow
Evommune, Inc. (EVMN)
Evommune, Inc. (EVMN)
source: myfinsight.com